Fitness of neuraminidase inhibitor-resistant influenza A viruses

Current Opinion in Virology

Volumn 1, Issue 6, 2011, Pages 574-581

  Baranovich, Tatiana ^a   Webster, Robert G ^a   Govorkova, Elena A ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER; OSELTAMIVIR; SIALIDASE INHIBITOR; ZANAMIVIR;

ARTICLE; FERRET; GUINEA PIG; HUMAN; IN VIVO STUDY; INFLUENZA A; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; NONHUMAN; PANDEMIC; PRIORITY JOURNAL; RISK ASSESSMENT; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS TRANSMISSION; VIRUS VIRULENCE;

EID: 82955236086     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2011.08.006     Document Type: Review

References (62)

1. K. Das, J.M. Aramini, L.C. Ma, R.M. Krug, and E. Arnold Structures of influenza A proteins and insights into antiviral drug targets Nat Struct Mol Biol 17 2010 530 538
2. A. Meijer, A. Lackenby, O. Hungnes, B. Lina, S. van-der-Werf, B. Schweiger, M. Opp, J. Paget, J. van-de-Kassteele, A. Hay, and M. Zambon Oseltamivir-resistant influenza virus A (H1H1), Europe, 2007-08 season Emerg Infect Dis 15 2009 552 560
3. V.M. Deyde, X. Xu, R.A. Bright, M. Shaw, C.B. Smith, Y. Zhang, Y. Shu, L.V. Gubareva, N.J. Cox, and A.I. Klimov Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide J Infect Dis 196 2007 249 257 (Pubitemid 47047464)
4. N.J. Dharan, L.V. Gubareva, J.J. Meyer, M. Okomo-Adhiambo, R.C. McClinton, S.A. Marshall, K. St George, S. Epperson, L. Brammer, and A.I. Klimov Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States JAMA 301 2009 1034 1041
5. O. Ferraris, and B. Lina Mutations of neuraminidase implicated in neuraminidase inhibitors resistance J Clin Virol 41 2008 13 19 (Pubitemid 350298978)
6. E. Domingo, L. Menendez-Arias, and J.J. Holland RNA virus fitness Rev Med Virol 7 1997 87 96 (Pubitemid 27314685)
7. J.W. Drake Rates of spontaneous mutation among RNA viruses Proc Natl Acad Sci U S A 90 1993 4171 4175 (Pubitemid 23134188)
8. N.T. Wetherall, T. Trivedi, J. Zeller, C. Hodges-Savola, J.L. McKimm-Breschkin, M. Zambon, and F.G. Hayden Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network J Clin Microbiol 41 2003 742 750 (Pubitemid 36184190)
9. T.J. Blick, T. Tiong, A. Sahasrabudhe, J.N. Varghese, P.M. Colman, G.J. Hart, R.C. Bethell, and J.L. McKimm-Breschkin Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en Virology 214 1995 475 484 (Pubitemid 26027775)
10. L.V. Gubareva, R.G. Webster, and F.G. Hayden Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay Antiviral Res 53 2002 47 61 (Pubitemid 33001554)
11. J.C. Obenauer, J. Denson, P.K. Mehta, X. Su, S. Mukatira, D.B. Finkelstein, X. Xu, J. Wang, J. Ma, and Y. Fan Large-scale sequence analysis of avian influenza isolates Science 311 2006 1576 1580
12. S. Duan, D.A. Boltz, J. Li, C.M. Oshansky, H. Marjuki, S. Barman, R.J. Webby, R.G. Webster, and E.A. Govorkova A novel genotyping and quantitative analysis of neuraminidase inhibitor-resistance associated mutations in influenza A viruses by single nucleotide polymorphism analysis Antimicrob Agents Chemother 2011 10.1128/AAC.00316-11
13. V.M. Deyde, M. Okomo-Adhiambo, T.G. Sheu, T.R. Wallis, A. Fry, N. Dharan, A.I. Klimov, and L.V. Gubareva Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses Antiviral Res 81 2009 16 24
14. Y. Suzuki, R. Saito, I. Sato, H. Zaraket, M. Nishikawa, T. Tamura, C. Dapat, I. Caperig-Dapat, T. Baranovich, and T. Suzuki Identification of oseltamivir resistance among pandemic and seasonal influenza A (H1N1) viruses by an His275Tyr genotyping assay using the cycling probe method J Clin Microbiol 49 2011 125 130
15. S. Duan, D.A. Boltz, P. Seiler, J. Li, K. Bragstad, L.P. Nielsen, R.J. Webby, R.G. Webster, and E.A. Govorkova Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets PLoS Pathog 6 2010 e1001022
16. M.A. Rameix-Welti, V. Enouf, F. Cuvelier, P. Jeannin, and S. van der Werf Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir PLoS Pathog 4 2008 e1000103
17. H.L. Yen, N.A. Ilyushina, R. Salomon, E. Hoffmann, R.G. Webster, and E.A. Govorkova Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo J Virol 81 2007 12418 12426 (Pubitemid 350085855)
18. J.A. Belser, K.J. Szretter, J.M. Katz, and T.M. Tumpey Use of animal models to understand the pandemic potential of highly pathogenic avian influenza viruses Adv Virus Res 73 2009 55 97
19. A.C. Lowen, S. Mubareka, T.M. Tumpey, A. Garcia-Sastre, and P. Palese The guinea pig as a transmission model for human influenza viruses Proc Natl Acad Sci U S A 103 2006 9988 9992 (Pubitemid 43993610)
20. C.D. O'Donnell, and K. Subbarao The contribution of animal models to the understanding of the host range and virulence of influenza A viruses Microbes Infect 13 2011 502 515
21. Y. Matsuoka, E.W. Lamirande, and K. Subbarao The ferret model for influenza Curr Protoc Microbiol 2009 (Chapter 15: Unit 15G.2)
22. J.A. Ives, J.A. Carr, D.B. Mendel, C.Y. Tai, R. Lambkin, L. Kelly, J.S. Oxford, F.G. Hayden, and N.A. Roberts The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo Antiviral Res 55 2002 307 317 (Pubitemid 34718130)
23. M. Baz, Y. Abed, P. Simon, M.E. Hamelin, and G. Boivin Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses J Infect Dis 201 2010 740 745
24. M.L. Herlocher, R. Truscon, S. Elias, H.L. Yen, N.A. Roberts, S.E. Ohmit, and A.S. Monto Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets J Infect Dis 190 2004 1627 1630 (Pubitemid 39411012)
25. T.G. Sheu, V.M. Deyde, M. Okomo-Adhiambo, R.J. Garten, X. Xu, R.A. Bright, E.N. Butler, T.R. Wallis, A.I. Klimov, and L.V. Gubareva Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008 Antimicrob Agents Chemother 52 2008 3284 3292
26. M. Kiso, K. Mitamura, Y. Sakai-Tagawa, K. Shiraishi, C. Kawakami, K. Kimura, F.G. Hayden, N. Sugaya, and Y. Kawaoka Resistant influenza A viruses in children treated with oseltamivir: descriptive study Lancet 364 2004 759 765 (Pubitemid 39165094)
27. A. Lackenby, O. Hungnes, S.G. Dudman, A. Meijer, W.J. Paget, A.J. Hay, and M.C. Zambon Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe Euro Surveill 13 2008 pii=8026. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=8026
28. J.D. Bloom, L.I. Gong, and D. Baltimore Permissive secondary mutations enable the evolution of influenza oseltamivir resistance Science 328 2010 1272 1275
29. H.L. Yen, L.M. Herlocher, E. Hoffmann, M.N. Matrosovich, A.S. Monto, R.G. Webster, and E.A. Govorkova Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility Antimicrob Agents Chemother 49 2005 4075 4084 (Pubitemid 41400949)
30. J. Carr, J. Ives, L. Kelly, R. Lambkin, J. Oxford, D. Mendel, L. Tai, and N. Roberts Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo Antiviral Res 54 2002 79 88 (Pubitemid 34327686)
31. P. Simon, B.P. Holder, X. Bouhy, Y. Abed, C.A. Beauchemin, and G. Boivin The I222V neuraminidase mutation has a compensatory role in replication of an oseltamivir-resistant influenza virus A/H3N2 E119V mutant J Clin Microbiol 49 2011 715 717
32. N.M. Bouvier, A.C. Lowen, and P. Palese Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol J Virol 82 2008 10052 10058
33. M.L. Herlocher, J. Carr, J. Ives, S. Elias, R. Truscon, N. Roberts, and A.S. Monto Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets Antiviral Res 54 2002 99 111 (Pubitemid 34327688)
34. M. Baz, Y. Abed, J. McDonald, and G. Boivin Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child Clin Infect Dis 43 2006 1555 1561 (Pubitemid 44901897)
35. F.S. Dawood, S. Jain, L. Finelli, M.W. Shaw, S. Lindstrom, R.J. Garten, L.V. Gubareva, X. Xu, C.B. Bridges, and T.M. Uyeki Emergence of a novel swine-origin influenza A(H1N1) virus in humans N Engl J Med 360 2009 2605 2615
36. L.V. Gubareva, A.A. Trujillo, M. Okomo-Adhiambo, V.P. Mishin, V.M. Deyde, K. Sleeman, H.T. Nguyen, T.G. Sheu, R.J. Garten, and M.W. Shaw Comprehensive assessment of 2009 pandemic influenza A(H1N1) virus drug susceptibility in vitro Antivir Ther 15 2010 1151 1159
37. M. Baz, Y. Abed, J. Papenburg, X. Bouhy, M.E. Hamelin, and G. Boivin Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis N Engl J Med 361 2009 2296 2297
38. S.B. Graitcer, L. Gubareva, L. Kamimoto, S. Doshi, M. Vandermeer, J. Louie, C. Waters, Z. Moore, K. Sleeman, and M. Okomo-Adhiambo Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States Emerg Infect Dis 17 2011 255 257
39. Q.M. Le, H.F. Wertheim, N.D. Tran, H.R. van Doorn, T.H. Nguyen, and P. Horby A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza N Engl J Med 362 2010 86 87
40. Centers for Disease Control Prevention (CDC) Oseltamivir-resistant 2009 pandemic influenza A(H1N1) virus infection in two summer campers receiving prophylaxis-North Carolina, 2009 MMWR Morb Mortal Wkly Rep 58 2009 969 972
41. A. Gulland First cases of spread of oseltamivir resistant swine flu between patients are reported in Wales BMJ 339 2009 b4975
42. L.F. Chen, N.J. Dailey, A.K. Rao, A.T. Fleischauer, I. Greenwald, V.M. Deyde, Z.S. Moore, D.J. Anderson, J. Duffy, and L.V. Gubareva Cluster of oseltamivir-resistant 2009 pandemic influenza A(H1N1) virus infections on a hospital ward among immunocompromised patients-North Carolina, 2009 J Infect Dis 203 2011 838 846
43. C.W. Seibert, M. Kaminski, J. Philipp, D. Rubbenstroth, R.A. Albrecht, F. Schwalm, S. Stertz, R.A. Medina, G. Kochs, and A. García-Sastre Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza a virus are not attenuated in the guinea pig and ferret transmission models J Virol 84 2010 11219 11226
44. M.E. Hamelin, M. Baz, Y. Abed, C. Couture, P. Joubert, E. Beaulieu, N. Bellerose, M. Plante, C. Mallett, and G. Schumer Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets PLoS Pathog 6 2010 e1001015
45. M.J. Memoli, A.S. Davis, K. Proudfoot, D.S. Chertow, R.J. Hrabal, T. Bristol, and J.K. Taubenberger Multidrug-resistant 2009 pandemic influenza A(H1N1) viruses maintain fitness and transmissibility in ferrets J Infect Dis 203 2011 348 357
46. M. Kiso, K. Shinya, M. Shimojima, R. Takano, K. Takahashi, H. Katsura, S. Kakugawa, M.T. Le, M. Yamashita, and Y. Furuta Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses PLoS Pathog 6 2010 e1001079
47. S. Duan, D.A. Boltz, P. Seiler, J. Li, K. Bragstad, L.P. Nielsen, R.J. Webby, R.G. Webster, and E.A. Govorkova Competitive transmissibility and fitness of oseltamivirsensitive and resistant pandemic influenza H1N1 viruses in ferrets Influenza Other Respi Viruses 5 Suppl. 1 2011 79 82
48. WHO: Weekly update on oseltamivir resistance to influenza A (H1N1) 2009 viruses. Available at: http://www.who.int/csr/disease/swineflu/ oseltamivirresistant20100820.pdf (Accessed 7 August 2011).
49. A. Hurt, R. Lee, S. Leang, L. Cui, Y. Deng, S. Phuah, N. Caldwell, K. Freeman, N. Komadina, and D. Smith Increased detection in Australia and Singapore of a novel influenza A(H1N1) 2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation Euro Surveill 16 2011 19884
50. A. Meijer, M. Jonges, F. Abbink, W. Ang, J. van Beek, M. Beersma, P. Bloembergen, C. Boucher, E. Claas, and G. Donker Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010 Antiviral Res 2011 July 15 (Epub ahead of print)
51. E.C. Claas, A.D. Osterhaus, R. van Beek, J.C. De Jong, G.F. Rimmelzwaan, D.A. Senne, S. Krauss, K.F. Shortridge, and R.G. Webster Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus Lancet 351 1998 472 477 (Pubitemid 28070093)
52. K. Subbarao, A. Klimov, J. Katz, H. Regnery, W. Lim, H. Hall, M. Perdue, D. Swayne, C. Bender, and J. Huang Characterization of an avian influenza A(H5N1) virus isolated from a child with a fatal respiratory illness Science 279 1998 393 396 (Pubitemid 28063376)
53. A.C. Hurt, P. Selleck, N. Komadina, R. Shaw, L. Brown, and I.G. Barr Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes Antiviral Res 73 2007 228 231
54. WHO: Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO. Available at: http://www.who.int/csr/disease/avian- influenza/country/cases-table-2011-06-22/en/index.html (Accessed 7 August 2011).
55. Q.M. Le, M. Kiso, K. Someya, Y.T. Sakai, T.H. Nguyen, K.H. Nguyen, N.D. Pham, H.H. Ngyen, S. Yamada, and Y. Muramoto Avian flu: Isolation of drug-resistant H5N1 virus Nature 437 2005 1108 (Pubitemid 41509341)
56. M.D. de Jong, T.T. Tran, H.K. Truong, M.H. Vo, G.J. Smith, V.C. Nguyen, V.C. Bach, T.Q. Phan, Q.H. Do, and Y. Guan Oseltamivir resistance during treatment of influenza A(H5N1) infection N Engl J Med 353 2005 2667 2672 (Pubitemid 41817715)
57. K.C. Earhart, N.M. Elsayed, M.D. Saad, L.V. Gubareva, A. Nayel, V.M. Deyde, A. Abdelsattar, A.S. Abdelghani, B.R. Boynton, and M.M. Mansour Oseltamivir resistance mutation N294S in human influenza A(H5N1) virus in Egypt J Infect Public Health 2 2009 74 80
58. M. Kiso, K. Takahashi, Y. Sakai-Tagawa, K. Shinya, S. Sakabe, Q.M. Le, M. Ozawa, Y. Furuta, and Y. Kawaoka T-705 (favipiravir) activity against lethal H5N1 influenza A viruses Proc Natl Acad Sci U S A 107 2010 882 887
59. E.A. Govorkova, N.A. Ilyushina, B.M. Marathe, J.L. McClaren, and R.G. Webster Competitive fitness of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model J Virol 84 2010 8042 8050
60. M. Kiso, S. Kubo, M. Ozawa, Q.M. Le, C.A. Nidom, M. Yamashita, and Y. Kawaoka Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses PLoS Pathog 6 2010 e1000786
61. N.A. Ilyushina, J.P. Seiler, J.E. Rehg, R.G. Webster, and E.A. Govorkova Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferrets PLoS Pathog 6 2010 e1000933
62. M. Kiso, M. Ozawa, M.T. Le, H. Imai, K. Takahashi, S. Kakugawa, T. Noda, T. Horimoto, and Y. Kawaoka Effect of an asparagine-to-serine mutation at position 294 in neuraminidase on the pathogenicity of highly pathogenic H5N1 influenza A virus J Virol 85 2011 4667 4672